









Markets
/
Stocks
/
nasdaq-kids
/

OrthoPediatrics Corp

KIDS

20.110USD

+0.860+4.47%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

504.21MMarket Cap

LossP/E TTM



OrthoPediatrics Corp

20.110

+0.860+4.47%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-18

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

47 / 207

Overall Ranking

144 / 4721

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 7 analysts

Buy

Current Rating

33.857

Target Price

+75.88%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 53 surgical and specialized bracing systems.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 67.41% year-on-year.

Overvalued

The company’s latest PE is -11.18, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 26.06M shares, decreasing 3.62% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 947.10K shares of this stock.

Financial Health

Currency: USD Updated: 2025-09-18

The company's current financial score is 7.85, which is higher than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 61.08M, representing a year-over-year increase of 15.68%, while its net profit experienced a year-over-year increase of 17.98%.

Score

Industry at a Glance

Previous score

7.85

Change



Financials

8.25

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.31

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.04

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.37

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.28

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-18

The company’s current valuation score is 1.20, which is lower than the Healthcare Equipment & Supplies industry's average of 2.00. Its current P/E ratio is -10.71, which is 8.61% below the recent high of -11.63 and -15.18% above the recent low of -12.33.

Score

Industry at a Glance

Previous score

1.20

Change

1.6

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 47/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-18

The company’s current earnings forecast score is 8.29, which is higher than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for OrthoPediatrics Corp is 35.00, with a high of 42.00 and a low of 22.00.

Score

Industry at a Glance

Previous score

8.29

Change

Support & Resistance

No Data

Analyst Rating

Based on 7 analysts

Buy

Current Rating

33.857

Target Price

+75.88%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

118

Total

Median

Average

Company name

Ratings

Analysts

OrthoPediatrics Corp

KIDS

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-18

The company’s current price momentum score is 6.24, which is lower than the Healthcare Equipment & Supplies industry's average of 6.45. Sideways: Currently, the stock price is trading between the resistance level at 21.71 and the support level at 17.88, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.24

Change

0.34

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.169

Sell

RSI(14)

48.795

Neutral

STOCH(KDJ)(9,3,3)

35.254

Buy

ATR(14)

0.846

High Vlolatility

CCI(14)

-58.502

Neutral

Williams %R

58.824

Sell

TRIX(12,20)

-0.101

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

19.632

Buy

MA10

20.009

Buy

MA20

20.434

Sell

MA50

20.741

Sell

MA100

21.130

Sell

MA200

22.505

Sell

Institutional Confidence

Currency: USD Updated: 2025-09-18

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 103.94%, representing a quarter-over-quarter decrease of 1.09%. The largest institutional shareholder is The Vanguard, holding a total of 947.10K shares, representing 3.78% of shares outstanding, with 0.40% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Squadron Capital LLC

6.90M

Brown Advisory

1.63M

+6.17%

Brown Capital Management, LLC

1.67M

-11.26%

BlackRock Institutional Trust Company, N.A.

1.14M

+1.05%

Braidwell LP

1.11M

Wellington Management Company, LLP

1.05M

-0.64%

Granahan Investment Management, LLC

667.06K

-15.17%

The Vanguard Group, Inc.

Star Investors

932.48K

+1.53%

Millennium Management LLC

656.58K

+55.33%

Dimensional Fund Advisors, L.P.

749.36K

+11.52%

Risk Assessment

Currency: USD Updated: 2025-09-18

The company’s current risk assessment score is 4.06, which is higher than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 1.04. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.